Upper GI
-
Disclaimer This entry is for professional discussion and educational reflection only. It does not constitute individual medical advice, formal guideline instruction, or a recommendation to deviate from local hepatobiliary, microbiology, or interventional radiology protocols. Clinical decisions should always be based on the individual patient, imaging findings, microbiology results, senior multidisciplinary input, and local policy. Some… Read more
-
or: when your writing is apparently too competent to be human Disclaimer This blog reflects my own views and experiences. It is written in a personal capacity, does not represent my employer, and contains no confidential or identifiable patient or staff information. Any resemblance to real conversations is, as ever, entirely coincidental. “I don’t believe… Read more
-
Disclaimer The following reflections are entirely my own and do not represent Somerset NHS Foundation Trust, the Upper GI service, or the F1 who mistook potassium for paracetamol that one time. Any resemblance to real persons—living, rotating, or attempting to clerk on pace—is purely coincidental. No F1s were harmed in the making of this blog,… Read more
-
Disclaimer Educational overview for clinicians and informed readers; not individual medical advice. Following my recent entry regarding LFT’s I though I follow this up with this blog entry: Why these three markers matter “Liver function tests” (LFTs) are misnamed: ALT and ALP are primarily injury/excretory markers, while bilirubin reports excretory capacity and, when high, overall… Read more
-
Pancreatic cysts in a high-definition era Routine cross-sectional imaging now detects fluid-filled lesions in up to 13 % of adults undergoing abdominal scans (Kruse & Paulson, 2024). Although most cysts are innocuous, a biologically important minority represent or can evolve into pancreatic ductal adenocarcinoma (PDAC). Pathologically they fall into two broad camps: Familial cancer syndromes… Read more
Pseudocyst 